🇺🇸 FDA
Patent

US 9890369

Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin lethal factor

granted A61KA61K38/164A61K38/465

Quick answer

US patent 9890369 (Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin lethal factor) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/164, A61K38/465, A61K38/4886, A61K47/6415